(Q37795414)

23 August 2017

Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia (English)

1 reference

23 August 2017

Peter J Bugelski

1

1 reference

23 August 2017

Amy Volk

2

1 reference

23 August 2017

Mindi R Walker

3

1 reference

23 August 2017

John H Krayer

4

1 reference

23 August 2017

Pauline Martin

5

1 reference

23 August 2017

Jacques Descotes

6

1 reference

23 August 2017

1 September 2010

1 reference

International Journal of Toxicology

23 August 2017

1 reference

23 August 2017

29

1 reference

23 August 2017

5

1 reference

23 August 2017

435-466

1 reference

Experiences with renal homotransplantation in the human: report of nine cases

23 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Biological effects of cyclosporin A: A new antilymphocytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Calcineurin inhibitors and rapamycin: cancer protection or promotion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The carcinogenicity of ciclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The immune system--is it relevant to cancer development, progression and treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immune surveillance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppressive drugs and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immune surveillance: a balance between protumor and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The flip side of immune surveillance: immune dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Malignancy after solid organ transplantation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Malignancy after heart transplantation: incidence, prognosis and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunodeficiency-associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Epstein-Barr virus-associated lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppressive therapy and post-transplant malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Skin cancer in organ transplant recipients--where do we stand today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Risk of nonmelanoma skin cancer with azathioprine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Role of viruses in the development of squamous cell cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cutaneous squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Evolving epidemiology of malignancies in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

HIV-associated Kaposi sarcoma and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Chronic inflammation: a common and important factor in the pathogenesis of neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

HIV-associated lymphomas and gamma-herpesviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Reversal of ultraviolet radiation-induced immune suppression by recombinant interleukin-12: suppression of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Toxic effects of ultraviolet radiation on the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Points to consider on the statistical analysis of rodent cancer bioassay data when incorporating historical control data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Neonatal mouse model: review of methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Role of natural killer cells in control of cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Ras family genes: an interesting link between cell cycle and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Behavioral and immune changes in v-Ha-ras transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Tg.AC genetically altered mouse: assay working group overview of available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

CB6F1-rasH2 mouse: overview of available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

P53+/- hemizygous knockout mouse: overview of available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immune selection in neoplasia: towards a microevolutionary model of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Non-melanoma skin cancer: what drives tumor development and progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Influence of total dose and dose rate in carcinogenicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effect of Cyclosporine on 3-Methylcholanthrene-Induced Carcinogenesis and Immune Responses in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Diversity of the promoting action of cyclosporine on the induction of murine lymphoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

All-trans retinoic acid protects against conversion of chemically induced and ultraviolet B radiation-induced skin papillomas to carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Ultraviolet radiation and immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Radiation carcinogenesis in mouse thymic lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Linearity vs non-linearity of dose response for radiation carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Radiation leukemogenesis in mice: loss of PU.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe ions, X rays or gamma Rays. Part II. Theoretical considerations based on microdosimetry and the initial induction of chr

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Facilitation of nodal metastasis from a non-immunogenic murine carcinoma by previous whole-body irradiation of tumour recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Differential gene signatures in rat mammary tumors induced by DMBA and those induced by fractionated gamma radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Radiation-induced mammary carcinogenesis in rodent models: what's different from chemical carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Increased skin carcinogenesis in caspase-activated DNase knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cyclosporine promotes the induction of thymic lymphomas in C57BL/6 mice initiated by a single dose of gamma-radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The Hedgehog receptor Patched controls lymphoid lineage commitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Maximizing mouse cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Tumor challenges in immunotoxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Application of tumor, bacterial and parasite susceptibility assays to study immune alterations induced by environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cancer in mice: effects of prednisolone or mepacrine alone and with cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

From clinical to human toxicology: linking animal research and risk assessment in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Species differences in the structure and function of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Species comparison of anatomical and functional immune system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Hazard identification and risk assessment for biologics targeting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rituximab: in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Nonhuman primate models to evaluate vaccine safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Tumorigenesis in High-Dose Total Body Irradiated Rhesus Monkeys—A Life Span Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Experimental Carcinoma of Liver in Macaque Monkeys Exposed to Diethylnitrosamine and Hepatitis B Virus2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Chemical carcinogenesis studies in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effects of dexamethasone on tumor-induced brain edema and its distribution in the brain of monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Brain-tumor chemotherapy. Pharmacological principles derived from a monkey brain-tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Alternative strategies for toxicity testing of species-specific biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Fourth biannual report of the Cochrane Haematological Malignancies Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppression and cancer: the ciclosporin case

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Squamous cell carcinoma arising in pemphigus vulgaris during immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Human papillomavirus type 16 associated with oral squamous carcinoma in a cardiac transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Monoclonal Epstein-Barr virus-related lymphoproliferative disorder following adult acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cancer after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Kaposi sarcoma in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Chronic toxicity of azathioprine and the effect of this immunosuppressant on liver tumor induction by the carcinogen N-hydroxy-N-2-fluorenylacetamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Role of reactive oxygen species in cell toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Regulation of growth-related genes by interleukin-6 in murine myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Natural killer cells in innate immunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Chemokines: key players in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Role of tumor-associated macrophages in tumor progression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cytokines in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Immune-cell system provides the development of extraneural tumors in the ethyl-nitrosourea model of neurocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Enhancement of chemically induced bladder carcinoma by cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effect of cyclosporine on carcinogenesis induced in rats by N-methyl-N'-nitro-N-nitrosoguanidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Osteomas in OF-1 mice: no alteration in biologic behavior during long-term treatment with cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Do the Immunosuppressive Drugs used as Treatment for Graft-versus-host Disease Directly Inhibit Lymphoid Tumor Cell Growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Inhibition of tumor growth in immunocompromised hosts by restoring type-2 immunity using infusion of G-CSF-treated allogeneic CD8+ leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

RAD inhibition of sarcoma growth: implications for laryngeal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

In vivo effects of dexamethasone on the tumor growth of glucocorticoid-sensitive Fu5-derived rat hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Leflunomide reduces the angiogenesis score and tumor growth of subcutaneously implanted colon carcinoma cells in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Origin of organisms infecting ventricular shunts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1091581810374654

21 January 2018

Identifiers

DOI

10.1177/1091581810374654

1 reference

23 August 2017

1 reference